Dr. Sridhar Guduri, MD

Dr. Guduri practices at Family Allergy & Asthma in Louisville, Kentucky.

Dr. Guduri's NPI, 1669436192, was assigned on April 13, 2006. Dr. Guduri holds Ohio license 35080871G.

Dr. Guduri's primary practice is Family Allergy & Asthma, at 9800 Shelbyville Rd, Louisville, KY 40223 in Jefferson County. The practice phone is (502) 429-8585.

Dr. Guduri's primary practice is Family Allergy & Asthma in Louisville, Kentucky. Dr. Guduri is also affiliated with Genesis Hospital. The medical group on file is Family Allergy & Asthma. Dmand AI also links Dr. Guduri to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Guduri practices, 3 sites in all. Vendor and product names are available with a free account.

Allergy and immunology is Dr. Guduri's primary specialty in the NPI Registry, under taxonomy code 207K00000X. Dr. Guduri is licensed in Ohio.

CMS data shows 2,654 Medicare services from Dr. Guduri across 6 procedure codes in 2024, for 77 Medicare patients. Medicare paid $17,517 for them. Every service was in an office.

CMS counts 77 Medicare patients who saw Dr. Guduri in 2024. The largest group is 65 to 74, with 40 patients. 71% of them have high cholesterol, and 65% have high blood pressure. 16% are also on Medicaid. Their average risk score is 0.88, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Guduri's median patient age at 45, with 65% women.

In 2024, Dr. Guduri wrote 739 Medicare Part D claims for 139 patients. 65% of them were for generic drugs. CMS names the drug for 659 of them, across 15 drugs with 11 or more claims each, at $74,665 in total drug cost. In 2023, CMS named 639 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Guduri for performance year 2024, reported as part of a group. Dr. Guduri accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links Dr. Guduri to 7 clinical trials, 4 of them phase 3 studies. 1 is still active or recruiting. Conditions studied include Migraine without Aura, Pulmonary Disease, Chronic Obstructive and Lung Diseases, Obstructive. Satsuma Pharmaceuticals, Inc. sponsors the most, 2. Open Payments lists research payments to Dr. Guduri that name 5 trials.

CMS Open Payments shows 550 general payments to Dr. Guduri from 32 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 69% of the total. AstraZeneca Pharmaceuticals LP paid the most, $6,304. It also lists 34 research payments totaling $134,999 from 2017 to 2024, naming 5 clinical trials.